Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients.
about
Cyclophosphamide, epirubicin and fluorouracil chemotherapy-induced alteration of haemostasis markers in breast cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cyclophosphamide, epirubicin a ...... ers in breast cancer patients.
@ast
Cyclophosphamide, epirubicin a ...... ers in breast cancer patients.
@en
type
label
Cyclophosphamide, epirubicin a ...... ers in breast cancer patients.
@ast
Cyclophosphamide, epirubicin a ...... ers in breast cancer patients.
@en
prefLabel
Cyclophosphamide, epirubicin a ...... ers in breast cancer patients.
@ast
Cyclophosphamide, epirubicin a ...... ers in breast cancer patients.
@en
P2093
P2860
P356
P1476
Cyclophosphamide, epirubicin a ...... ers in breast cancer patients.
@en
P2093
Chengxue Dang
Dongmin Chang
Yong Zhang
Yongchun Song
P2860
P304
P356
10.3892/MCO.2015.584
P577
2015-06-24T00:00:00Z